|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/2803 | (2013.01) | ||
| A61K 39/395 | (2006.01) | ||
| A61K2039/505 | (2013.01) | ||
| C07K2317/24 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 31/17 | (2013.01) | ||
| C07K2317/76 | (2013.01) | ||
| A61K2039/545 | (2013.01) | ||
| A61K 39/3955 | (2013.01) | ||
| C07K2317/90 | (2013.01) | ||
| A61P 35/02 | (2018.01) |
| (11) | Number of the document | 3642242 |
| (13) | Kind of document | T |
| (96) | European patent application number | 18820011.7 |
| Date of filing the European patent application | 2018-06-21 | |
| (97) | Date of publication of the European application | 2020-04-29 |
| (45) | Date of publication and mention of the grant of the patent | 2024-02-07 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2018/038798 |
| Date | 2018-06-21 |
| (87) | Number | WO 2018/237168 |
| Date | 2018-12-27 |
| (30) | Number | Date | Country code |
| 201762523182 P | 2017-06-21 | US |
| (72) |
MAJETI, Ravindra , US
CHAO, Mark P. , US
LIU, Jie , US
VOLKMER, Jens-Peter , US
WEISSMAN, Irving L. , US
|
| (73) |
The Board of Trustees of the Leland Stanford
Junior University ,
Office of the General Counsel
Building 170, Third Floor, Main Quad
P.O. Box 20386, Stanford, CA 94305-2038,
US
Forty Seven, Inc. , 333 Lakeside Drive, Foster City, CA 94404, US |
| (54) | DOSING PARAMETERS FOR CD47 TARGETING THERAPIES TO HEMATOLOGIC MALIGNANCIES |
| DOSING PARAMETERS FOR CD47 TARGETING THERAPIES TO HEMATOLOGIC MALIGNANCIES |